Remove Animal Testing Remove Clinical Pharmacology Remove Disease
article thumbnail

Drug repurposing: The benefits, risks and what we learned from Covid-19

Drug Discovery World

Diana Spencer summarises the key messages from the ‘Drug Repurposing: Challenges and Opportunities’ Symposium held at the 19th World Congress of Basic & Clinical Pharmacology (WCP) 2023. She urged that new methodologies are needed to reduce human and animal testing to establish safety and efficacy.

article thumbnail

Analysis Life Sciences Thank You The 53 regulations that FDA is currently working on

Agency IQ

Specifically, FDA is proposing to classify blood irradiators intended for the prevention of transfusion-associated graft versus host disease into Class II and blood irradiators intended for prevention of metastasis by irradiating intra-operatively salvaged blood of cancer patients undergoing surgery into Class III.